Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Clinical trial NCT00635557 · UNKNOWN

Trial details

NCT number: NCT00635557
Sponsor: Myrexis Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2008-03-01
Primary completion: 2010-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.